Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Emary KRW., Golubchik T., Aley PK., Ariani CV., Angus BJ., Bibi S., Blane B., Bonsall D., Cicconi P., Charlton S., Clutterbuck E., Collins AM., Cox T., Darton T., Dold C., Douglas AD., Duncan CJA., Ewer K., Flaxman A., Faust SN., Ferreira DM., Feng S., Finn A., Folegatti PM., Fuskova M., Galiza E., Goodman AL., Green CM., Green CA., Greenland M., Hallis B., Heath PT., Hay J., Hill HC., Jenkin D., Kerridge S., Lazarus R., Libri V., Lillie PJ., Ludden C., Marchevsky NG., Minassian AM., McGregor AC., Farooq Mujadidi Y., Phillips DJ., Plested E., Pollock KM., Robinson H., Smith A., Song R., Snape MD., Sutherland RK., Thomson EC., Toshner M., Turner DPJ., Vekemans J., Villafana TL., Williams CJ., Hill AVS., Lambe T., Gilbert SC., Voysey M., Ramasamy MN., Pollard A., Group OCOVIDVT.

DOI

10.2139/ssrn.3779160

Type

Preprint

Publication Date

07/02/2021

Permalink Original publication